© 2022 MJH Life Sciences™ and Contemporary OB/GYN. All rights reserved.
Vulvovaginal Candidiasis
Essentials of vulvovaginal dermatology
August 08, 2022
Correct terms and education can help normalize the conversation for patients.
FDA grants ibrexafungerp sNDA priority review for RVVC
August 02, 2022
If approved, ibrexafungerp would be the first and only approved therapy for both the treatment of vulvovaginal candidiasis (VVC) and the prevention of recurrent vulvovaginal candidiasis (RVVC).
RVVC treatment drug oteseconazole now commercially available in US
July 26, 2022
Mycovia Pharmaceuticals recently announced US availability of oteseconazole capsules for the treatment of recurrent vulvovaginal candidiasis in women without reproductive potential.
Phase 3 ibrexafungerp data shows promising results for acute VVC treatment
July 21, 2022
The CANDLE open-label sub-study enrolled 24 patients with RVVC who failed to respond to fluconazole treatment, which was given as an initial 3-dose treatment over 7 days.
Pregnancy outcomes affected by aerobic vaginitis
July 21, 2022
Aerobic vaginitis (AV) in pregnant Vietnamese women correlated with a higher risk of puerperal sepsis and negative pregnancy outcomes.
Biotics battle vaginal fungal biofilms
July 08, 2022
Eradicating vaginal biofilms involving Candida species requires synergistic combinations of antifungal drugs with pre-, pro-, post-, and synbiotics, according to a recent Frontiers in Microbiology review.1
Probiotics may increase cure rates for bacterial vaginosis
July 01, 2022
A cocktail of different probiotic species may be more effective than probiotic monotherapies, according to a recent literature review.
Survey investigates incidence and lifetime prevalence rate of VVC in the US
June 21, 2022
Results from this study can help increase understanding of the estimated incidence and lifetime prevalence of VVC in the US.
Berberine promising therapy to treat vulvovaginal candidiasis
June 21, 2022
Vaginal yeast infections were successfully treated with berberine, a biologically active herbal alkaloid, according to a study published in Frontiers in Pharmacology.